Eastwood Bio-medical Canada Inc · TSXV:EBM
Eastwood Bio-medical Canada — Investor Presentation (July 2020)
44 slides from Eastwood Bio-medical Canada's investor presentation, Jul 15, 2020
Slide 1: Eastwood Bio-Medical Canada Inc.
Eastwood Bio-Medical Canada Inc. (EBM) July 15, 2020 1130-4871 Shell Road, Richmond, BC, Canada 1 V6X 3Z6
Slide 2: Forward-Looking Statement
Forward-Looking Statement This presentation contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "b
Slide 3: Disclaimer
Disclaimer Although the data found in this Investor Deck have been produced and processed from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. This disclaimer applies to bo
Slide 4: Disclaimer
Disclaimer Except for the claims allowed by Health Canada Product Licenses 80000196, 80000364, 80000365, 80000477, 80000481, 80000504, 80000866, the Singapore Health Science Authority CDA (HSU) 40:43/01-B(V), the National Pharmaceutical Administration NPA (CPM) 6:06 /1 Vol 19, the Food and Drug Admi
Slide 5: Disclaimer
Disclaimer Eastwood Bio-medical Canada Inc. (EBM) is not liable for any information provided on this Investor Deck with regard to recommendations regarding the mentioned products for any health purposes. The products or claims made about specific nutrients or products have not been evaluated by the
Slide 6: Eastwood Bio-Medical Canada Inc. is located at Richmond, British Columbia
Eastwood Bio-Medical Canada Inc. is located at Richmond, British Columbia, Canada near the Vancouver International Airport. 6
Slide 7: Canadian History in Diabetes Leadership
Canadian History in Diabetes Leadership Canada has long been considered the global pioneer of the diabetes industry. In 1922, Frederick Grant Banting discovered insulin, which is considered one of the most important discoveries of the 20th century. The Nobel Foundation awarded his team the Nobel Pri
Slide 8: Who We Are
Who We Are A company specializing in metabolic disorders such as diabetes, obesity, hypertension, and Alzheimer‟s disease. We have successfully developed over 70 Eleotin® products including over 60 Health Canada (Canadian FDA) approved products. Advertising Standards Canada (ASC) approved our flagsh
Slide 9: Advertising Standards Canada Approval Number
Advertising Standards Canada Approval Number Please see Disclaimers on slides 3, 4, and 5. 9
Slide 10: Who We Are
Who We Are As of 2018, over 500,000 users are estimated to have used and benefited from Eleotin®. (An estimated 200,000 users as of 2014, or as of the ASC approval stamp) More than four international health associations strongly recommend (endorsed) Eleotin®. Eleotin® was the recipient of Best Diabe
Slide 11: EBM: The Recent Focus of Financial Analysts and Investors
EBM: The Recent Focus of Financial Analysts and Investors Company production capacity „recently‟ has increased to: ▰ Up to 3 million capsules can be produced and 10,000 bottles can be packaged per day. ▰ A half million dollar worth of products in retail value can be produced daily. ▰ Up to $7 millio
Slide 12: EBM: The Recent Focus of Financial Analysts and Investors
EBM: The Recent Focus of Financial Analysts and Investors 12
Slide 13: EBM: The Recent Focus of Financial Analysts and Investors
EBM: The Recent Focus of Financial Analysts and Investors New Product Approvals and Licenses (Over 100 NPN Numbers). 13
Slide 14: June 2018, Eastwood Bio-Medical Canada Enters Binding Terms for Asian Exports
June 29 2018, Eastwood Bio-Medical Canada Enters Binding Terms for Asian Exports ▰ On June 29 2018, EBM announced entering binding terms for Asian exports. The Company is optimistic that this will result in an increase in revenues. ▰ New manufacturing capabilities allow the Company to finally start
Slide 15: Stock Draws International Attention
Stock Draws International Attention 15
Slide 16: Stock Draws International Attention
Stock Draws International Attention 16
Slide 17: Stock Draws International Attention
Stock Draws International Attention 17
Slide 18: Market Potential: Prevalence of Diabetes By IDF Region
Market Potential: Prevalence of Diabetes By IDF Region 18 Global Report on Diabetes – WHO 2016
Slide 19: Market Potential: Prevalence of Alzheimer's and Dementia
Market Potential: Prevalence of Alzheimer‟s and Dementia 19 World Alzheimer's Report 2015
Slide 20: Market Potential: Prevalence of Hypertension
Market Potential: Prevalence of Hypertension Global Prevalence of Hypertension over 1.3 Billion 20 Global Health Observatory - WHO 2013
Slide 21: Market Values of Diabetes, Hypertension and Alzheimer's
Market Values of Diabetes, Hypertension and Alzheimer‟s ▰Type 2 diabetes market to more than double, to $64 billion by 2026 ▰Global hypertension market will reach USD $32 billion by the end 2 of 2020 ▰The global Alzheimer's market is expected to $10.4 billion in 2021 1. GlobalData’s report: PharmaPo
Slide 22: Our Claim: The Only Option
Our Claim: The Only Option We believe that our products are the „only‟ natural sourced option for those inflicted with these diseases. We also believe we will remain the only option in the near future. Here is why... 22 Please see Disclaimers on slides 3, 4, and 5.
Slide 23: Advantage #1: Modes of Action Known
Advantage #1: Modes of Action Known Folkloric Pharmaceu- Traditional Other Herbal Treatments/ tical Drugs Chinese Eleotin® Products Alternative and Insulin Medicine Treatments Known - Can Known - Can be used with be safely used other Unknown Unknown Unknown with other pharmaceu- pharmaceutica tical
Slide 24: Advantage #2: Long Term Effects
Advantage #2: Long Term Effects Folkloric Pharmaceu- Traditional Other Herbal Treatments/ tical Drugs and Chinese Eleotin® Products Alternative Insulin Medicine Treatments Semi- None None Unknown None permanent efficacy ● With proven insulin resistance reduction, Eleotin® provides semi- permanent lo
Slide 25: Advantage #3: Preventive Effects
Advantage #3: Preventive Effects Folkloric Pharmaceu- Traditional Other Herbal Treatments/ tical Drugs Chinese Eleotin® Products Alternative and Insulin Medicine Treatments No No No No Yes ● A person who does not have diabetes can use Eleotin® for general health and preventive purposes. Other treatm
Slide 26: Conclusion
Conclusion Folkloric Pharmaceutical Other Herbal Traditional Treatments/ Eleotin® Drugs and Insulin Products Chinese Medicine Alternative Treatments Short term and invasive Shotgun approach. Shotgun approach. Shotgun approach. treatment. Toxic Long term and Most of them rely Most of them rely Most o
Slide 27: As a Result,
As a Result, Advertising Standards Canada (ASC) approved Eleotin® to be marketed as “World‟s #1 Doctor recommended Natural Source Healthy Blood Glucose Promoting Product available in Canada”. ● World‟s No.1 Doctor recommended: Over 3000+ doctors ● Over 2,500 Newspaper & Television Acclaims (includin
Slide 28: Trends Favourable For Eleotin Products (1)
Trends Favourable For Eleotin® Products (1) The deadly side effects of common pharmaceutical drugs for metabolic disorders are being reported and published with increasing frequency. 28
Slide 29: Trends Favourable For Eleotin Products (2)
Trends Favourable For Eleotin® Products (2) Accordingly, Eleotin®'s unique position as the world‟s # 1 scientific supported natural and safe health promoter for metabolic disorder will become more widely accepted. Eastwood believes Eleotin® products will eventually replace most of pharmaceutical dru
Slide 30: International Health Associations Endorsements of Eleotin
International Health Associations Endorsements of Eleotin® These are unsolicited third party opinions from unaffiliated individuals based on their own independent research. Except for claims referred to on slides 3, 4, and 5, EBM takes no 30 responsibility for any claims.
Slide 31: Recommendations of Medical Professionals
Recommendations of Medical Professionals Dr. Chu, Beijing China Dr. L. Lipskaya, Bacteriologist “Because of Eleotin my “After I started using Eleotin, I felt an husband doesn‟t need any improvement in my health conditions. pharmaceutical drugs. He‟s Now I recommend Eleotin to every normal now.” pers
Slide 32: Clinical Studies, Publications, Approvals, and Licenses
Clinical Studies, Publications, Approvals, and Licenses 32 Please see Disclaimers on slides 3, 4, and 5.
Slide 33: Clinical Studies, Publications, Approvals, and Licenses
Clinical Studies, Publications, Approvals, and Licenses Please see Disclaimers on 33 slides 3, 4, and 5.
Slide 34: Clinical Studies, Publications, Approvals, and Licenses
Clinical Studies, Publications, Approvals, and Licenses Comments on Eleotin® by the Korean National Diabetes Association 34 Please see Disclaimers on slides 3, 4, and 5.
Slide 35: Clinical Studies, Publications, Approvals, and Licenses
Clinical Studies, Publications, Approvals, and Licenses Comments on Eleotin® by the Korean Pharmaceutical Manufacturers‟ Association 35 Please see Disclaimers on slides 3, 4, and 5.
Slide 36: Africa's Best Diabetic & Hypertension Management Drug in 2010
Africa's Best Diabetic & Hypertension Management Drug in 2010* *These are unsolicited third party opinions based on independent research. Except for claims referred to on slides 3, 4, and 5, EBM takes no responsibility for any claims. Please see Disclaimers on slides 3, 4, and 5. 36
Slide 37: Growth Strategies & Research Projects: (1)
Growth Strategies & Research Projects: (1) ▰ 1. Having established a world leadership in the area of metabolic disorder treatments through the exclusive proprietary technology of P- 700, claimed to be „World #1 technology to lower insulin resistance by all natural means‟, Eastwood continues to devel
Slide 38: Growth Strategies & Research Projects: (2)
Growth Strategies & Research Projects: (2) ▰ 3. Having „all natural‟ products that can replace or substitute synthetic prescription drugs such as statins, ibuprofen, estrogen with little or no side effects, we will continue to expand the list of synthetic prescription drugs which we can replace. ▰ 4
Slide 39: Testimonials
Testimonials We have over 5,000 video testimonials on Youtube by users and doctors with all real names and many contact information to verify. 39 Please see Disclaimers on slides 3, 4, and 5.
Slide 40: Established Retail Lines
Established Retail Lines Eleotin® Bentley ● Helps promote healthy glucose levels. ● Long-term blood glucose normalization effects. ● General health improvement. Eleotin® Ma5 ● Powerful anti-oxidation powers that are preserved superbly. ● High quality Vitamin C group ingredients. 40
Slide 41: Established Retail Lines
Established Retail Lines Eleotin® LBM ● For hyperactivity of the liver (high blood pressure). ● To cut the vicious cycle between high blood sugar and high blood pressure caused by prescription drugs. Eleotin® Pedo-Protection Socks ● Anti-Fungal & Anti-Bacterial. ● Auto Regulating Mesh Top. ● Treated
Slide 42: Founder - Dr. Youngsoo Kim
Founder - Dr. Youngsoo Kim ● Advises Various Governments and senior management of numerous Korean firms including Hyundai, LG, and Samsung ● CEO of Mutsumi Enterprises Canada Corp. 1991-1995 ● Vice President of Toshin Butsuryu (Toyota Automobile Group Japan) 1991-1995 ● Assistant Professor of Financ
Slide 43: Board of Directors
Board of Directors Yunji Kim Peter Chen Dr. Marcus Kuypers President, CEO and CFO and Director Director Director ● Executive Director ● Medical Doctor ● President since April of Proterra ● Physician at AB Staffing 2013, Director since Management Group since November 2011 October 2012 Inc. ● Accretiv
Slide 44: Yunji Kim Unit 1130-4871 Shell Road Richmond, B.C. Canada, V6X 3Z6
Yunji Kim Unit 1130-4871 Shell Road Richmond, B.C. Canada, V6X 3Z6 604.247.2100 or 1.888.669.4372 yunjikim@eastwoodcos.com www.eleotin.ca 44
Eastwood Bio-Medical Canada — Investor Presentation (July 2020) on 6ix